Hence, in sum, it is currently claimed that activation of TRPML1 and TRPML3 would be beneficial in treating certain infectious diseases, while in the case of TRPML2, it remains unclear whether activation or inhibition may be more beneficial. This evidence concerns the gene MCOLN2 and infectious disease.